NYMOX PHARMACEUTICAL CORPORATION Issue Of Equity
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Issue Of Equity of $6.95 million for the 9-month period ending 2021-09-30, per its 6-K filed 2021-11-12.
Discontinued › Notes
ifrs-full:IssueOfEquity · last filed 2021-11-12
- NYMOX PHARMACEUTICAL CORPORATION issue of equity for the quarter ending 2018-09-30 was $2.00M.
- NYMOX PHARMACEUTICAL CORPORATION issue of equity for the quarter ending 2018-06-30 was $6.10M.
- NYMOX PHARMACEUTICAL CORPORATION issue of equity for the quarter ending 2018-03-31 was $1.83M.
| Period end | Issue Of Equity 3 month | Issue Of Equity 6 month | Issue Of Equity 9 month | Issue Of Equity 12 month |
|---|---|---|---|---|
| 2021-09-30 | $6.95M 6-K · filed 2021-11-12 | |||
| 2020-09-30 | $8.69M 6-K · filed 2021-11-12 | |||
| 2018-09-30 | $2.00M derived: 6-K 9 month − 6-K 6 month · filed 2018-11-13 | $8.10M derived: sum of 2 quarters · filed 2018-11-13 | $9.93M 6-K · filed 2018-11-13 | |
| 2018-06-30 | $6.10M derived: 6-K 6 month − 6-K 3 month · filed 2018-08-13 | $7.93M 6-K · filed 2018-08-13 | ||
| 2018-03-31 | $1.83M 6-K · filed 2018-05-15 | |||
| 2017-12-31 | $5.04M 20-F · filed 2020-03-30 | |||
| 2016-12-31 | $6.15M 20-F · filed 2019-03-29 | |||
| 2015-12-31 | $3.73M 20-F · filed 2018-03-30 |